tailieunhanh - Trastuzumab in advanced breast cancer – a decade of experience in Germany

Trastuzumab was registered in 2000 for the treatment of metastatic breast cancer, both as monotherapy and combination therapy with paclitaxel. In this prospective, non-interventional observation study, the 10-year experience with trastuzumab in the routine management of HER2-positive breast cancer was reviewed. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN